Astrogliosis in the adult and developing CNS: Is there a role for proinflammatory cytokines?

NeuroToxicology

Volumn 22, Issue 5, 2001, Pages 607-618

  Little, A R ^a   O'Callaghan, J P ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Astrogliosis; Chemokines; CNS; Cytokines; GFAP; Gliosis; Inflammation

Indexed keywords

CHEMOKINE; CYTOKINE; GLIAL FIBRILLARY ACIDIC PROTEIN; GROWTH FACTOR;

ASTROCYTE; ASTROCYTOSIS; BRAIN INJURY; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; CYTOKINE PRODUCTION; HUMAN; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; ASTROCYTES; CENTRAL NERVOUS SYSTEM; CYTOKINES; GLIOSIS; HUMANS; INFLAMMATION;

EID: 0035214672     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-813X(01)00032-8     Document Type: Conference Paper

References (188)

1. Transgenic expression of IFN-α in the central nervous system of mice protects against lethal neurotrophic viral infection but induces inflammation and neurodegeneration
2. Studies on a cerebellar 50,000 Da protein associated with cerebellar hypoplasia in jaundiced Gunn rats: Its identity with glial fibrillary acidic protein as evidenced by the improved immunoblotting method
3. Increase of interleukin-6 mRNA in the spinal cord following peripheral nerve injury in the rat: Potential role of IL-6 in neuropathic pain
4. C10 is a novel chemokine expressed in experimental inflammatory demyelinating disorders that promotes recruitment of macrophages to the central nervous system
5. Trimethyl tininduced neuronal damage in the rat brain: Comparative studies using silver degeneration stains, immunocytochemistry and immunoassay for neuronotypic and gliotypic proteins
6. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines
7. Blood to brain transport of interleukin links the immune and central nervous systems
8. Relative contributions of peripheral and central sources to levels of IL-1α in the cerebral cortex of mice: Assessment with species-specific enzyme immunoassays
9. Bidirectional transport of interleukin-1α across the blood-brain barrier
10. Human interleukin (IL)-1α, murine IL-1α and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism
11. Interleukin-1α in blood has direct access to cortical brain cells
12. Penetration of interleukin-6 across the murine blood-brain barrier
13. Passage of cytokines across the blood-brain barrier
14. Permeability of the blood-brain barrier to soluble cytokine receptors
15. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms
16. Differences between adult and neonatal rats in their astroglial response to spinal injury
17. Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children
18. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones
19. Glial fibrillary acidic protein in mutant mice with deficiency of myelination: Quaking and jimpy
20. Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1r) family. Delineation of a new class of IL-1r-related proteins based on signaling
21. Stimulation of tumor necrosis factor-α production by mycoplasmas and inhibition by dexamethasone in cultured astrocytes
22. Mycoplasma triggering of nitric oxide production by central nervous system glial cells and its inhibition by glucocorticoids
23. Quantitative changes in the synaptic vesicle proteins synapsin I and p38 and the astrocyte-specific protein glial fibrillary acidic protein are associated with chemical-induced injury to the rat central nervous system
24. Cellular localization and temporal elevation of tumor necrosis factor-α, interleukin-1α, and transforming growth factor-1β mRNA in hippocampal injury response induced by trimethyl tin
25. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors
26. Excitotoxic injury stimulates glial fibrillary acidic protein mRNA expression in perinatal rat brain
27. Hypoxic-ischemic brain injury stimulates glial fibrillary acidic protein mRNA and protein expression in neonatal rats
28. Peripheral administration of lipopolysaccharide induces activation of microglial cells in rat brain
29. Lipopolysaccharide induces expression of tumour necrosis factor-α in rat brain: Inhibition by methylprednisolone and by rolipram
30. Transgenic mice and cytokine actions in the brain: Bridging the gap between structural and functional neuropathology
31. Role of cytokines in demyelinating disease studied in transgenic mice
32. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6
33. Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie
34. Cerebral expression of multiple cytokine genes in mice with lymphocytic choriomeningitis
35. Transgenic models to study the actions of cytokines in the central nervous system
36. Expression of JE (monocyte chemoattractant protein-1) is induced by sciatic axotomy in wild type rodents but not in C57BL/Wld(s) mice
37. Prion protein (PrP) is not involved in the pathogenesis of spongiform encephalopathy in transgenic mice expressing interleukin-6 in the brain
38. Cytokines in the central nervous system: Expression of macrophage colony stimulating factor and its receptor during development
39. Reactive gliosis as a consequence of interleukin-6 expression in the brain: Studies in transgenic mice
40. Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice
41. Coexpression of glial fibrillary acidic protein and vimentin in the central and peripheral nervous systems of the twitcher mutant
42. Control of astrocytosis by interleukin-1 and transforming growth factor-1β in human brain
43. The progression and topographic distribution of interleukin-1β expression after permanent middle cerebral artery occlusion in the rat
44. Overexpression of interleukin-6 in the central nervous system of transgenic mice increases central but not systemic proinflammatory cytokine production
45. Biology of interleukin-1
46. Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis
47. Acute-phase cytokines IL-1β and TNF-α in brain development
48. Basic fibroblast growth factor (bFGF) injection activates the glial reaction in the injured adult rat brain
49. Regulation of glial intermediate filaments in astrogliosis
50. Glial fibrillary acidic (GFA) protein immunocytochemistry in development and neuropathology
51. GFAP and astrogliosis
52. Astrocytic response to injury
53. IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage
54. Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets
55. TNF-α regulates transforming growth factor-α expression in regenerating murine liver and isolated hepatocytes
56. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor
57. Chemokine expression in rat stab wound brain injury
58. Inflammation in traumatic brain injury: Role of cytokines and chemokines
59. Chemokine inhibition in rat stab wound brain injury using antisense oligodeoxynucleotides
60. Regulation and function of central nervous system chemokines
61. Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain
62. Expression of chemokines RANTES, MIP-1α and GRO-α correlates with inflammation in acute experimental autoimmune encephalomyelitis
63. Chemokine expression in GKO mice (lacking interferon-γ) with experimental autoimmune encephalomyelitis
64. Chemokine expression in murine experimental allergic encephalomyelitis
65. Behavioral and neurophysiological effects of CNS expression of cytokines in transgenic mice
66. Developmental neurotoxicity: Evaluation of testing procedures with methylazoxymethanol and methylmercury
67. Induction of cyclooxygenase-2 by platelet-derived growth factor (PDGF) and its inhibition by dexamethasone are independent of NF-κB/IκB transcription factors
68. Trimethyl tin-induced neuropathy in the rat: Interaction with thermoregulation
69. Endogenous glucocorticoids down regulate central effects of interleukin-1β on body temperature and behaviour in mice
70. Adrenalectomy enhances pro-inflammatory cytokines gene expression, in the spleen, pituitary and brain of mice in response to lipopolysaccharide
71. Differential and time-dependent expression of monocyte chemoattractant protein-1 mRNA by astrocytes and macrophages in rat brain: Effects of ischemia and peripheral lipopolysaccharide administration
72. Brain interleukin-1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease
73. Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution
74. Glial-neuronal interactions in Alzheimer's disease: The potential role of a 'cytokine cycle' in disease progression
75. Leukaemia inhibitory factor expression is inhibited by glucocorticoids through post-transcriptional mechanisms
76. Physiological and pathological roles of interleukin-6 in the central nervous system
77. Murine tumor necrosis factor-α is transported from blood to brain in the mouse
78. Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier
79. Cytokine accumulations in CSF of multiple sclerosis patients: Frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6
80. Selective chemokine mRNA expression following brain injury
81. Transgenic expression of interleukin-6 in the central nervous system regulates brain metallothionein-I and -III expression in mice
82. Temporal modulation of cytokine expression following focal cerebral ischemia in mice
83. Induction of acute phase gene expression by brain irradiation
84. An infection-based model of neurodevelopmental damage
85. Astrocyte activation correlates with cytokine production in central nervous system of Trypanosoma brucei brucei-infected mice
86. Astrocytal changes in the white matter of jimpy mice: Immunohistochemistry using antisera to glial fibrillary acidic protein
87. Bone morphogenetic proteins: Neurotrophic roles for midbrain dopaminergic neurons and implications of astroglial cells
88. CNTF regulation of astrogliosis and the activation of microglia in the developing rat central nervous system
89. Glucocorticoids inhibit the transcriptional induction of JE, a platelet-derived growth factor-inducible gene
90. Expression of TGF-β stimulated clone-22 (TSC-22) in mouse development and TGF-β signalling
91. Effects of dexamethasone on microglial activation in vivo: Selective downregulation of major histocompatibility complex class II expression in regenerating facial nucleus
92. Interleukin-6 and transforming growth factor-1β mRNAs are induced in rat facial nucleus following motoneuron axotomy
93. Expression of cytokine genes and increased nuclear factor-κB activity in the brains of scrapie-infected mice
94. Astrological responses to CNS trauma
95. Impaired neurological activation in interleukin-6 deficient mice
96. Expression of glial fibrillary acidic protein in the CNS and PNS of murine globoid cell leukodystrophy, the twitcher
97. Expression of cyclooxygenase-2 mRNA after global ischemia is regulated by AMPA receptors and glucocorticoids
98. Multifunctional cytokine expression by human coronary endothelium and regulation by monokines and glucocorticoids
99. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
100. LIF: Not just a leukemia inhibitory factor
101. Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6
102. Transforming growth factor-1β induces neuronal and astrocyte genes: Tubulin-1α, glial fibrillary acidic protein and clusterin
103. Dexamethasone destabilizes cyclooxygenase-2 mRNA by inhibiting mitogenactivated protein kinase p38
104. Glucocorticoids selectively inhibit the transcription of the interleukin-1β gene and decrease the stability of interleukin-1β mRNA
105. Interleukin-6 is not expressed in activated microglia and in reactive astrocytes in response to lesion of rat basal forebrain cholinergic system as demonstrated by combined in situ hybridization and immunocytochemistry
106. Differential injury-dependent glial expression of interleukins-1α, -β, and interleukin-6 in rat brain
107. Neuropathology of twitcher mice: Examination by histochemistry, immunohistochemistry, lectin histochemistry and Fourier transform infrared microspectroscopy
108. TNF-α, IL-1α, and IL-1β gene expression is not altered in response to trimethyl tin (TMT)-induced damage in the adult rat hippocampus
109. Systemic administration of trimethyl tin or LPS induce different profiles of chemokines
110. Cytokine and growth factor gene expression in response to trimethyl tin (TMT)-induced neurotoxicity in the adult rat hippocampus
111. Differential regulation of cyclo-oxygenase-1 and cyclo-oxygenase-2 gene expression by lipopolysaccharide treatment in vivo in the rat
112. Endogenous interleukin-1 receptor antagonist is neuroprotective
113. The role of tumor necrosis factor-α in chemical-induced hepatotoxicity
114. Trimethyl tin increases interleukin (IL)-1α, IL-6 and tumor necrosis factor-α mRNA levels in rat hippocampus
115. Reactive astrocytes - A review
116. Induction of immunoreactive interleukin-1β and tumor necrosis factor-α in the brains of rabies virus infected rats
117. Gene expression in astrocytes after neural injury
118. Tumor necrosis factor-α and its receptors in relapsing-remitting multiple sclerosis
119. Regulation of prostaglandin synthesis by glucocorticoids
120. Cellular signaling roles of TGF-β, TNF-α and -β APP in brain injury responses and Alzheimer's disease
121. Granulocyte-macrophage colony-stimulating factor crosses the blood-brain and blood-spinal cord barriers
122. MCP-1, MCP-2, and MCP-3 expression in multiple sclerosis lesions: An immunohistochemical and in situ hybridization study
123. Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury
124. Hematolymphopoietic and inflammatory cytokines in neural development
125. Tumor necrosis factor-α, interleukin-1 and related cytokines in brain development: Normal and pathological
126. Interactions of the nervous and immune systems in development, normal brain homeostasis, and disease
127. RANTES production by cytokine-stimulated nasal fibroblasts: Its inhibition by glucocorticoids
128. Interleukin-7 is trophic for embryonic neurons and is expressed in developing brain
129. Neurotoxicity of D-amphetamine in the C57BL/6J and CD-1 mouse. Interactions with stress and the adrenal system
130. Regulation of interleukin-1βinduced interleukin-6 gene expression in human fibroblast-like synoviocytes by glucocorticoids
131. Human first trimester forebrain cells express genes for inflammatory and anti-inflammatory cytokines
132. Dexamethasone in acute stroke
133. The role of tumour necrosis factor, interleukin 6, interferon-γ and inducible nitric oxide synthase in the development and pathology of the nervous system
134. Cytokine induction of cytosolic phospholipase A2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells
135. Exposure to acute stress induces brain interleukin-1β protein in the rat
136. Astrocyte responses to CNS injury
137. Quantitative aspects of reactive gliosis: A review
138. Quantitative features of reactive gliosis following toxicant-induced damage of the CNS
139. Cerebellar hypoplasia in the Gunn rat is associated with quantitative changes in neurotypic and gliotypic proteins
140. Diethyldithiocarbamate increases distribution of cadmium to brain but prevents cadmium-induced neurotoxicity
141. Acute exposure of the neonatal rat to triethyl tin results in persistent changes in neurotypic and gliotypic proteins
142. Assessment of chemically-induced alterations in brain development using assays of neuron- and glia-localized proteins
143. Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
144. Glucocorticoids regulate the synthesis of glial fibrillary acidic protein in intact and adrenal ectomized rats but do not affect its expression following brain injury
145. Quantitative aspects of drug and toxicant-induced astrogliosis
146. Inflammatory cytokines in the brain: Does the CNS shape immune responses?
147. Permeability of the blood-brain and blood-spinal cord barriers to interferons
148. Tumor necrosis factor-α a neuromodulator in the CNS
149. Effects of the inhibition of cyclo-oxygenase-1 or 2- or 5-lipoxygenase on the activation of the hypothalamicpituitary-adrenal axis induced by interleukin-1β in the male rat
150. Intracerebral injection of interferon-γ inhibits the astrocyte proliferation following the brain injury in the 6-day-old rat
151. The inflammatory response in the CNS
152. An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis
153. Response of glia, mast cells and the blood brain barrier, in transgenic mice expressing interleukin-3 in astrocytes, an experimental model for CNS demyelination
154. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor-α
155. A role for transforming growth factor-α as an inducer of astrogliosis
156. Peripheral injections of Freund's adjuvant in mice provoke leakage of serum proteins through the blood-brain barrier without inducing reactive gliosis
157. Inflammatory cytokines: Putative regulators of neuronal and neuro-endocrine function
158. Do chemokines mediate leukocyte recruitment in post-traumatic CNS inflammation?
159. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis
160. Chemokines in immunemediated inflammation of the central nervous system
161. TNF-α expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines
162. Reactive astrocytes: Cellular and molecular cues to biological function
163. Down-regulation of cytokineinduced cyclo-oxygenase-2 transcript isoforms by dexamethasone: Evidence for post-transcriptional regulation
164. Astrogliosis in the neonatal and adult murine brain post-trauma: Elevation of inflammatory cytokines and the lack of requirement for endogenous interferon-γ
165. The role of interleukin-1 in acute neurodegeneration and stroke: Pathophysiological and therapeutic implications
166. Interleukins and cerebral ischaemia
167. Glucocorticoids potentiate ischemic injury to neurons: Therapeutic implications
168. Cytokine expression in the rat central nervous system following perinatal Borna disease virus infection
169. Expression of BMP-6, a TGF-β related morphogenetic cytokine, in rat radial glial cells
170. Regulation by interleukin-1β of formation of a line of delimiting astrocytes following prenatal trauma to the brain of the mouse
171. Closed head injury triggers early production of TNF-α and IL-6 by brain tissue
172. Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor
173. Glial cytokines as neuropathogenic factors in HIV infection: Pathogenic similarities to Alzheimer's disease
174. Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis
175. Exacerbation of damage and altered NF-KB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury
176. Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes
177. In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis
178. Differential role of TNF-α and IFN-γ in the brain of rats with chronic relapsing autoimmune encephalomyelitis
179. Herpes simplex virus replication-induced expression of chemokines and proinflammatory cytokines in the eye: Implications in herpetic stromal keratitis
180. Growth factor function in the development and maintenance of midbrain dopaminergic neurons: Concepts, facts and prospects for TGF-β
181. Interleukin-1β and interferon-γ differentially regulate release of monocyte chemotactic protein-1 and interleukin-8 by human bronchial epithelial cells
182. Coronavirus infection and demyelination. Development of inflammatory lesions in Lewis rats
183. Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice
184. Cytokine indices in Alzheimer's temporal cortex: No changes in mature IL-1β or IL-1ra but increases in the associated acute phase proteins IL-6, α-2macroglobulin and C-reactive protein
185. Expression of tumor necrosis factor-α (TNF-α)-cross-reactive proteins during early chick embryo development
186. Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-1β
187. Gene expression of IL-10 in relationship to TNF-α, IL-1β and IL-2 in the rat brain following middle cerebral artery occlusion
188. Regulation of cyclooxygenase-2 (COX-2) in rat renal cortex by adrenal glucocorticoids and mineralocorticoids